Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Self Injection Market Analysis 2017-2024 - Companies Profiles, Size, Share, Growth, Trends and Forecasts - Research and Markets

Research and Markets
Posted on: 31 Oct 17

The "Global Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.

In this report, Global self-injection market is projected to reach USD 52.437.46 million by 2024 from USD 21.950.41 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024.

Major factors driving the growth of market are the rising cases of chronic diseases, increasing demand of self-injection devices.

The global self-injection market is segmented on the basis of product type, application, usage pattern, mode of administration, end user, distribution channel and geography:

  • On the basis of product type, market is segmented into 4 types, namely, auto injectors, wearable injectors, needle free injectors (NFI), and pen injectors.
  • On the basis of application, the global self-injection market is segmented into oncology, hormonal disorders, autoimmune diseases, orphan diseases, and others.
  • On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
  • Based on distribution channel, market is segmented into, Pharmacy stores, hospital pharmacy, direct tender and online pharmacy.
  • Based on mode of administration, the global self-injection market is segmented into circulatory, organs, skin and central nervous system.
  • On the basis of end user, the market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.

Market Dynamics


  • Rising Cases of Chronic Diseases
  • Rising Demand of Self-Injection Devices
  • Growth of Biologics Market
  • Technological Advancements and Innovations in Drug Delivery Market


  • High Cost of Development
  • Strict Regulatory Framework


  • Increasing Demand for Generic and Biosimilar Drugs
  • Generics
  • Biosimilars
  • Increasing Demand for Contraceptive Injectables
  • Increasing Demand for Self-Administration of Drugs


  • Alternative Route of Drug Administration
  • Product Recall
  • Stability of Products
  • Sterility of Injections

Becton, Dickinson and Company is going to dominate the global self-injection market following with, Novo Nordisk, Sanofi and Pfizer, along with others such as:

  • Antares Pharma, Bespak
  • Gerresheimer AG
  • Impax Laboratories, Inc.
  • Mylan N.V.
  • Sandoz
  • Unilife Corporation
  • West Pharmaceutical Services, Inc. and
  • Ypsomed.

For more information about this report visit

View source version on

Business Wire

Last updated on: 31/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.